A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.
Dengue is a rapidly emerging, mosquito-borne viral infection, with an estimated 400 million infections occurring annually. To gain insight into dengue immunity, we characterized 145 human monoclonal antibodies (mAbs) and identified a previously unknown epitope, the envelope dimer epitope (EDE), that...
Main Authors: | Dejnirattisai, W, Wongwiwat, W, Supasa, S, Zhang, X, Dai, X, Rouvinsky, A, Jumnainsong, A, Edwards, C, Quyen, N, Duangchinda, T, Grimes, J, Tsai, W, Lai, C, Wang, W, Malasit, P, Farrar, J, Simmons, C, Zhou, Z, Rey, F, Mongkolsapaya, J, Screaton, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Nature Publishing Group
2014
|
Similar Items
-
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
by: Dejnirattisai, W, et al.
Published: (2014) -
Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus
by: Renner, M, et al.
Published: (2018) -
Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity.
by: Midgley, C, et al.
Published: (2012) -
Potent neutralizing human monoclonal antibodies preferentially target mature dengue virus particles: implication for novel strategy of dengue vaccine
by: Tsai, W, et al.
Published: (2018) -
The alteration of NK cells phenotypes related to the functions and dengue disease outcomes
by: Napas Taechasan, et al.
Published: (2024-07-01)